Article metrics

Download PDFPDF

Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2021

AbstractFullPdf
Dec 2019110
Jan 202017174
Feb 202015156
Mar 202028284
Apr 202019196
May 2020434312
Jun 202046462
Jul 202034344
Aug 2020363615
Sep 2020555518
Oct 2020525245
Nov 2020616142
Dec 2020353422
Jan 2021606040
Feb 2021292916
Mar 2021707046
Apr 2021444435
May 2021484823
Total693692340